RADX
Radiopharm
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
RADX Profile
Radiopharm Theranostics Limited
A clinical stage radiotherapy company
Pharmaceutical
Invalid Date
11/27/2024
NASDAQ Stock Exchange
7
06-30
Depository Receipts (Ordinary Shares)
Level 3, 62 Lygon Street, Carlton VIC 3053, Australia
Clinical Stage Radiation Therapy Company
Radiopharm Theranostics Limited was incorporated under the laws of Australia in February 2021. The Company is a clinical-stage radiotherapy company focused on the development of radiopharmaceutical products for the diagnosis and treatment of areas of high unmet medical need. The company develops targeted and scientifically validated radiopharmaceutical technologies that are in preclinical and clinical development. These techniques cover molecules of all sizes, including peptides, fatty acids, and antibody targets linked to medical quality radioisotopes.